Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxfendazole vs Triclabendazole for Chronic Fascioliasis
NCT06367361Phase 2Not yet recruiting
- Sponsor
- Universidad Peruana Cayetano Heredia
- Start
- Aug 2026
- Primary completion
- Apr 2029
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of oxfendazole in fascioliasis, sponsored by Universidad Peruana Cayetano Heredia. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
oxfendazole
03
Conditions
fascioliasis
Beyond the preview
Go deeper on NCT06367361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06367361.